Charles River Laboratories International, Inc.CRLNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank10
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P10
Near historical low
vs 3Y Ago
-0.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -67.14% |
| Q3 2025 | 5.28% |
| Q2 2025 | 50.66% |
| Q1 2025 | 34.18% |
| Q4 2024 | -60.70% |
| Q3 2024 | 38.31% |
| Q2 2024 | 203.58% |
| Q1 2024 | -64.42% |
| Q4 2023 | 2.23% |
| Q3 2023 | 72.78% |
| Q3 2023 | 3119.26% |
| Q2 2023 | -98.28% |
| Q4 2022 | 141.34% |
| Q3 2022 | -9.36% |
| Q2 2022 | 200.56% |
| Q1 2022 | -83.01% |
| Q4 2021 | 9.48% |
| Q3 2021 | -14.96% |
| Q2 2021 | -1.43% |
| Q1 2021 | 181.44% |
| Q4 2020 | -66.57% |
| Q3 2020 | 11.52% |
| Q2 2020 | 216.09% |
| Q1 2020 | -63.31% |
| Q4 2019 | -3.19% |
| Q3 2019 | 15.19% |
| Q2 2019 | 5696.79% |
| Q1 2019 | -102.63% |
| Q4 2018 | -24.80% |
| Q3 2018 | -8.22% |
| Q2 2018 | 225.96% |
| Q1 2018 | -66.79% |
| Q4 2017 | 158.00% |
| Q3 2017 | -55.87% |
| Q3 2017 | 375.18% |
| Q2 2017 | -79.95% |
| Q4 2016 | 48.10% |
| Q3 2016 | -9.88% |
| Q2 2016 | 121.12% |
| Q1 2016 | -59.45% |